Stem cell‐derived exosomes in the treatment of melasma and its percutaneous penetration

黄褐斑 医学 经皮 渗透(战争) 治疗效果 间充质干细胞 皮肤病科 外科 病理 运筹学 工程类
作者
Ting Wang,Hangqi Gao,Dezhi Wang,Chaoyu Zhang,Kailun Hu,Haoruo Zhang,Jian Lin,Xiaosong Chen
出处
期刊:Lasers in Surgery and Medicine [Wiley]
卷期号:55 (2): 178-189 被引量:18
标识
DOI:10.1002/lsm.23628
摘要

Melasma is a refractory skin disease due to its complex pathogenesis and difficult treatment. Studies have found that human umbilical cord mesenchymal stem cell-derived exosomes (hUCMSC-Exos) could serve as a novel cell-free therapeutic strategy in regenerative and esthetic medicine. It could potentially treat melasma, but the skin barrier is a challenge. In this study, we aim to explore the safety and efficacy of hUCMSC-Exos in the treatment of melasma and the means to promote its percutaneous penetration.In the animal study about the effect of penetration, percutaneous penetration of PKH67-labeled hUCMSC-Exos was studied under microneedles, 1565 nm nonablative fractional laser (NAFL), and a plasma named Peninsula Blue Aurora Shumin Master (PBASM) treatments, observed by confocal laser scanning microscopy. In the clinical application study, 60 patients with melasma treated in our department were divided into four groups. NAFL combined with normal saline treatment was used for Group A. Microneedles, NAFL, and PBASM combined with hUCMSC-Exos treatments were used for Groups B, C, and D, respectively. Each patient received four treatments at 1-month intervals. Assessments were done using the degree of pain posttreatment, melasma area and severity score, improvement rate, physician global assessment score, satisfaction, and complications.In the animal study about the effect of penetration, hUCMSC-Exos can penetrate the deep dermis under microneedles, NAFL, and PBASM treatments. In the clinical application study, compared with Group A, Groups B, C, and D showed significantly improved therapeutic effect and patient satisfaction (p < 0.05), and there was no significant difference among Groups B, C, and D.(p > 0.05). Patients in Group B reported higher pain levels than those in the other three groups (p < 0.05); the treatment experience of patients in Group D was better.hUCMSC-Exos can improve the symptoms of melasma safely and effectively. Compared with microneedles, NAFL and PBASM can also achieve a good effect toward promoting penetration. These findings are worthy of exploration and clinical application.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
大脸猫完成签到 ,获得积分10
2秒前
DT完成签到,获得积分10
2秒前
3秒前
xzj发布了新的文献求助10
3秒前
科研通AI2S应助谢富杰采纳,获得10
4秒前
今夕何夕完成签到,获得积分10
5秒前
fuiee发布了新的文献求助10
9秒前
丑123完成签到,获得积分20
9秒前
LIVE完成签到,获得积分10
10秒前
丑123发布了新的文献求助10
13秒前
14秒前
fuiee完成签到,获得积分10
15秒前
17秒前
xzj完成签到,获得积分10
17秒前
zrs发布了新的文献求助10
21秒前
22秒前
金金金金完成签到,获得积分10
24秒前
帅气的宽发布了新的文献求助10
24秒前
yu发布了新的文献求助10
27秒前
Wangran完成签到 ,获得积分10
28秒前
30秒前
32秒前
ww完成签到,获得积分10
33秒前
刘星完成签到 ,获得积分10
34秒前
Yolen LI完成签到,获得积分10
34秒前
moon发布了新的文献求助10
35秒前
35秒前
少华完成签到,获得积分10
37秒前
皮蛋发布了新的文献求助10
37秒前
39秒前
顾矜应助科研通管家采纳,获得10
40秒前
Ava应助科研通管家采纳,获得10
40秒前
大个应助科研通管家采纳,获得10
40秒前
乐乐应助科研通管家采纳,获得10
40秒前
天天快乐应助科研通管家采纳,获得10
40秒前
打打应助科研通管家采纳,获得10
41秒前
斯文败类应助科研通管家采纳,获得10
41秒前
充电宝应助科研通管家采纳,获得10
41秒前
英姑应助科研通管家采纳,获得10
41秒前
共享精神应助科研通管家采纳,获得10
41秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
ISCN 2024 – An International System for Human Cytogenomic Nomenclature (2024) 3000
Continuum Thermodynamics and Material Modelling 2000
Encyclopedia of Geology (2nd Edition) 2000
105th Edition CRC Handbook of Chemistry and Physics 1600
Maneuvering of a Damaged Navy Combatant 650
Fashion Brand Visual Design Strategy Based on Value Co-creation 350
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3777911
求助须知:如何正确求助?哪些是违规求助? 3323444
关于积分的说明 10214462
捐赠科研通 3038671
什么是DOI,文献DOI怎么找? 1667606
邀请新用户注册赠送积分活动 798207
科研通“疑难数据库(出版商)”最低求助积分说明 758304